251 related articles for article (PubMed ID: 36224723)
1. A competitive binding-mass spectrometry strategy for high-throughput evaluation of potential critical quality attributes of therapeutic monoclonal antibodies.
Zhang Z; Yan Y; Wang S; Li N
MAbs; 2022; 14(1):2133674. PubMed ID: 36224723
[TBL] [Abstract][Full Text] [Related]
2. Hyphenation of strong cation exchange chromatography to native mass spectrometry for high throughput online characterization of charge heterogeneity of therapeutic monoclonal antibodies.
Ma F; Raoufi F; Bailly MA; Fayadat-Dilman L; Tomazela D
MAbs; 2020; 12(1):1763762. PubMed ID: 32370592
[TBL] [Abstract][Full Text] [Related]
3. Full-length recombinant antibodies from
Rashid MH
MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
[TBL] [Abstract][Full Text] [Related]
5. Multiattribute Monitoring of Antibody Charge Variants by Cation-Exchange Chromatography Coupled to Native Mass Spectrometry.
Haberger M; Heidenreich AK; Hook M; Fichtl J; Lang R; Cymer F; Adibzadeh M; Kuhne F; Wegele H; Reusch D; Bonnington L; Bulau P
J Am Soc Mass Spectrom; 2021 Aug; 32(8):2062-2071. PubMed ID: 33687195
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species.
Glover ZK; Wecksler A; Aryal B; Mehta S; Pegues M; Chan W; Lehtimaki M; Luo A; Sreedhara A; Rao VA
MAbs; 2022; 14(1):2122957. PubMed ID: 36151884
[TBL] [Abstract][Full Text] [Related]
7. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.
Aoyama M; Hashii N; Tsukimura W; Osumi K; Harazono A; Tada M; Kiyoshi M; Matsuda A; Ishii-Watabe A
MAbs; 2019 Jul; 11(5):826-836. PubMed ID: 30990348
[TBL] [Abstract][Full Text] [Related]
8. Non-targeted characterization of attributes affecting antibody-FcγRIIIa V158 (CD16a) binding via online affinity chromatography-mass spectrometry.
Woodall DW; Dillon TM; Kalenian K; Padaki R; Kuhns S; Semin DJ; Bondarenko PV
MAbs; 2022; 14(1):2004982. PubMed ID: 34978527
[TBL] [Abstract][Full Text] [Related]
9. Impact of Tryptophan Oxidation in Complementarity-Determining Regions of Two Monoclonal Antibodies on Structure-Function Characterized by Hydrogen-Deuterium Exchange Mass Spectrometry and Surface Plasmon Resonance.
Hageman T; Wei H; Kuehne P; Fu J; Ludwig R; Tao L; Leone A; Zocher M; Das TK
Pharm Res; 2018 Dec; 36(1):24. PubMed ID: 30536043
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
[TBL] [Abstract][Full Text] [Related]
11. Ultrasensitive Characterization of Charge Heterogeneity of Therapeutic Monoclonal Antibodies Using Strong Cation Exchange Chromatography Coupled to Native Mass Spectrometry.
Yan Y; Liu AP; Wang S; Daly TJ; Li N
Anal Chem; 2018 Nov; 90(21):13013-13020. PubMed ID: 30280893
[TBL] [Abstract][Full Text] [Related]
12. Insights into ultra-low affinity lipase-antibody noncovalent complex binding mechanisms.
Hecht ES; Mehta S; Wecksler AT; Aguilar B; Swanson N; Phung W; Dubey Kelsoe A; Benner WH; Tesar D; Kelley RF; Sandoval W; Sreedhara A
MAbs; 2022; 14(1):2135183. PubMed ID: 36284469
[TBL] [Abstract][Full Text] [Related]
13. A generic workflow for the characterization of therapeutic monoclonal antibodies-application to daratumumab.
Duivelshof BL; Fekete S; Guillarme D; D'Atri V
Anal Bioanal Chem; 2019 Jul; 411(19):4615-4627. PubMed ID: 30617394
[TBL] [Abstract][Full Text] [Related]
14. High-Resolution IMS-MS to Assign Additional Disulfide Bridge Pairing in Complementarity-Determining Regions of an IgG4 Monoclonal Antibody.
Deslignière E; Botzanowski T; Diemer H; Cooper-Shepherd DA; Wagner-Rousset E; Colas O; Béchade G; Giles K; Hernandez-Alba O; Beck A; Cianférani S
J Am Soc Mass Spectrom; 2021 Oct; 32(10):2505-2512. PubMed ID: 34437803
[TBL] [Abstract][Full Text] [Related]
15. Investigation of anomalous charge variant profile reveals discrete pH-dependent conformations and conformation-dependent charge states within the CDR3 loop of a therapeutic mAb.
Lan W; Valente JJ; Ilott A; Chennamsetty N; Liu Z; Rizzo JM; Yamniuk AP; Qiu D; Shackman HM; Bolgar MS
MAbs; 2020; 12(1):1763138. PubMed ID: 32432964
[TBL] [Abstract][Full Text] [Related]
16. LC-MS Approach to Decipher a Light Chain Chromatographic Peak Splitting of a Monoclonal Antibody.
Liu Y; VanAernum Z; Zhang Y; Gao X; Vlad M; Feng B; Cross R; Kilgore B; Newman A; Wang D; Schuessler HA; Richardson DD; Chadwick JS
Pharm Res; 2023 Dec; 40(12):3087-3098. PubMed ID: 37936013
[TBL] [Abstract][Full Text] [Related]
17. A generic platform to couple affinity chromatography with native mass spectrometry for the analysis of therapeutic monoclonal antibodies.
Cotham VC; Liu AP; Wang S; Li N
J Pharm Biomed Anal; 2023 May; 228():115337. PubMed ID: 36933319
[TBL] [Abstract][Full Text] [Related]
18. Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing.
Lakayan D; Haselberg R; Gahoual R; Somsen GW; Kool J
Anal Bioanal Chem; 2018 Dec; 410(30):7837-7848. PubMed ID: 30328504
[TBL] [Abstract][Full Text] [Related]
19. An Online Two-Dimensional Approach to Characterizing the Charge-Based Heterogeneity of Recombinant Monoclonal Antibodies Using a 2D-CEX-AEX-MS Workflow.
Kumar S; Peruri V; Rathore AS
J Am Soc Mass Spectrom; 2023 Dec; 34(12):2801-2810. PubMed ID: 37994779
[TBL] [Abstract][Full Text] [Related]
20. The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensity.
Knight MJ; Floret L; Patel N; O'Hara J; Rodriguez E
MAbs; 2022; 14(1):2127172. PubMed ID: 36198003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
